United States : Ambagon Therapeutics Launches with $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline

Media coverage

• Title	United States : Ambagon Therapeutics Launches with $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline
  Media name/outlet	Mena Report
  Country/Territory	United Kingdom
  Date	24/01/22
  Persons	Luc Brunsveld, Christian Ottmann

• Title	United States : Ambagon Therapeutics Launches with $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline
  Media name/outlet	TendersInfo – News
  Date	24/01/22
  Persons	Luc Brunsveld, Christian Ottmann